|
Re: You're right 10bagr, you didn't sway me....
|
4
|
Resverlogix Corp.
|
Jan 31, 2019 11:23PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 10:59PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
7
|
Resverlogix Corp.
|
Jan 31, 2019 10:29PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
7
|
Resverlogix Corp.
|
Jan 31, 2019 10:00PM
|
|
Re: Sarah's reply to my email
|
8
|
Resverlogix Corp.
|
Jan 31, 2019 08:11PM
|
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 12:51PM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
5
|
Zenith Epigenetics
|
Jan 30, 2019 12:14PM
|
|
Re: What impact would a PR like this have?
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 05:45PM
|
|
Re: What impact would a PR like this have?
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 04:17PM
|
|
Re: Every day the same lately....
|
2
|
Resverlogix Corp.
|
Jan 28, 2019 05:00PM
|
|
Re: Every day the same lately....
|
2
|
Resverlogix Corp.
|
Jan 28, 2019 04:05PM
|
|
Re: 250 MACE scenario question
|
2
|
Resverlogix Corp.
|
Jan 24, 2019 08:21PM
|
|
Re: 250 MACE scenario question
|
2
|
Resverlogix Corp.
|
Jan 24, 2019 06:35PM
|
|
Re: 250 MACE scenario question
|
2
|
Resverlogix Corp.
|
Jan 24, 2019 06:04PM
|
|
Re: 250 MACE scenario question
|
3
|
Resverlogix Corp.
|
Jan 23, 2019 08:10PM
|
|
Re: Question for the board!
|
5
|
Zenith Epigenetics
|
Jan 22, 2019 01:39PM
|
|
Re: Nasdaq has 4 starndards for listing, we don't meet the criteria of any....
|
4
|
Resverlogix Corp.
|
Jan 21, 2019 09:33PM
|
|
Re: Dosing to end of trial
|
3
|
Resverlogix Corp.
|
Jan 21, 2019 04:01PM
|
|
Re: Shrinking MACE event rate
|
5
|
Resverlogix Corp.
|
Jan 20, 2019 09:48AM
|
|
Re: Shrinking MACE event rate
|
5
|
Resverlogix Corp.
|
Jan 20, 2019 09:22AM
|
